Option Care Health, Inc. $OPCH Stock Sold by Riverbridge Partners LLC

Riverbridge Partners LLC cut its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 6.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 609,930 shares of the company’s stock after selling 40,638 shares during the quarter. Riverbridge Partners LLC’s holdings in Option Care Health were worth $13,717,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Reyes Financial Architecture Inc. bought a new stake in shares of Option Care Health in the 3rd quarter worth about $28,000. Covestor Ltd increased its position in shares of Option Care Health by 254.2% during the 3rd quarter. Covestor Ltd now owns 1,445 shares of the company’s stock worth $33,000 after purchasing an additional 1,037 shares in the last quarter. Harbor Investment Advisory LLC bought a new position in Option Care Health during the 2nd quarter valued at about $48,000. Nykredit A S bought a new position in Option Care Health during the 2nd quarter valued at about $56,000. Finally, Public Employees Retirement System of Ohio bought a new position in Option Care Health during the 2nd quarter valued at about $66,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Price Performance

Shares of OPCH stock opened at $31.65 on Wednesday. Option Care Health, Inc. has a 52 week low of $18.01 and a 52 week high of $36.80. The stock has a market capitalization of $4.74 billion, a PE ratio of 19.56, a PEG ratio of 1.93 and a beta of 0.47. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.06 and a current ratio of 1.54. The stock’s fifty day moving average is $27.62 and its 200-day moving average is $26.32.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Wednesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.49. The business had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.48 billion. Option Care Health had a return on equity of 19.06% and a net margin of 3.74%. The firm’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same period in the previous year, the business posted $0.45 earnings per share. Equities research analysts expect that Option Care Health, Inc. will post 1.70 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have weighed in on OPCH. Citizens Jmp cut shares of Option Care Health from a “market outperform” rating to a “hold” rating in a research note on Wednesday, October 7th. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and lifted their target price for the company from $28.00 to $32.05 in a research note on Tuesday, October 6th. Truist Financial set a $32.05 target price on shares of Option Care Health in a research note on Wednesday, October 7th. William Blair downgraded Option Care Health from an “outperform” rating to a “market perform” rating in a report on Tuesday, October 6th. Finally, Barrington Research lowered Option Care Health from an “outperform” rating to a “hold” rating in a research report on Wednesday, October 7th. Two analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company’s stock. According to MarketBeat.com, Option Care Health currently has a consensus rating of “Hold” and an average price target of $29.48.

Option Care Health Profile

Option Care Health, Inc. is a U.S. provider of home and alternate-site infusion therapy services. The company coordinates infusion care for patients who need medications or nutritional support administered outside a hospital, including in their homes or at infusion centers. Its services include specialty pharmacy, nursing, care coordination and clinical support. Option Care Health provides therapies for a range of acute and chronic conditions, including immune disorders, infections, bleeding disorders and nutritional needs.